Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 25 Mar 2025

Screening and exploration of neoadjuvant “de-escalation” therapy for early breast cancer

in Pharmacology of Anti-Cancer Drugs

Nana Zhang
Ming Shan
Zhenfeng Huang
Fei Gao
Bingqi Xu
Wenli Kang
Jian Zhang
Li Song
Jun Liu
Jiawei Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1574665

464 views

Original Research

Published on 25 Mar 2025

Milciclib-mediated CDK2 inhibition to boost radiotherapy sensitivity in colorectal cancer

in Pharmacology of Anti-Cancer Drugs

Junjie Ma
Shanshan Wu
Xinxin Yang
Shuying Shen
Yiqian Zhu
Ruoqi Wang
Wei Xu
Yue Li
Haixin Zhu
Youyou Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1557925

515 views

Original Research

Published on 24 Mar 2025

Efficacy and safety of PD-1/PD-L1 inhibitors combined with tyrosine kinase inhibitors as first-line treatment for hepatocellular carcinoma: a meta-analysis and trial sequential analysis of randomized controlled trials

in Pharmacology of Anti-Cancer Drugs

Peng Tang
Fei Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1535444

668 views

Original Research

Published on 21 Mar 2025

Identifying acute myeloid leukemia subtypes based on pathway enrichment

in Pharmacology of Anti-Cancer Drugs

Ling Zhong
Jiangti Luo
Junze Dong
Xiang Yang
Xiaosheng Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1557112

724 views

Mini Review

Published on 21 Mar 2025

Circulating tumor DNA: a revolutionary approach for early detection and personalized treatment of bladder cancer

in Pharmacology of Anti-Cancer Drugs

Yan Zhou
Rongzhong Wang
Mingtang Zeng
Sijia Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1551219

590 views

Case Report

Published on 21 Mar 2025

Case Report: Posterior reversible encephalopathy syndrome after lenvatinib treatment for hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Minchun Chen
Jing Shen
Rongrong Jia
Mingze Chang
Jingyi Zhang
Jie Zheng
Runqing Xue
Lulu Guo
Kangkang Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1487009

464 views

Original Research

Published on 21 Mar 2025

Histidine-rich glycoprotein inhibits TNF-α–induced tube formation in human vascular endothelial cells

in Pharmacology of Anti-Cancer Drugs

Omer Faruk Hatipoglu
Takashi Nishinaka
Kursat Oguz Yaykasli
Shuji Mori
Masahiro Watanabe
Takao Toyomura
Masahiro Nishibori
Satoshi Hirohata
Hidenori Wake
Hideo Takahashi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1561628

542 views

Original Research

Published on 21 Mar 2025

Crocin promotes ferroptosis in gastric cancer via the Nrf2/GGTLC2 pathway

in Pharmacology of Anti-Cancer Drugs

Nan Yan
Gaofu Li
Linglin Zhao
Qijing Guo
Jie Yang
Jianhong Liu
Wei Zhou
Yue Gao
Yushuang Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1527481

781 views

Original Research

Accepted on 20 Mar 2025

RNF180 weakened the lipid droplet formation and subsequent chemoresistance by destabilizing ACC1 and ACLY in esophageal cancer

in Pharmacology of Anti-Cancer Drugs

NING LI
Daofu Shen
NanChang Yin
Zheng-Guo Cui
Huachuan Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1525431

Original Research

Published on 20 Mar 2025

A novel ubiquitin-related genes-based signature demonstrated values in prognostic prediction, immune landscape sculpture and therapeutic options in laryngeal cancer

in Pharmacology of Anti-Cancer Drugs

Lu Liu
Bing Wang
Xiaoya Ma
Lei Tan
Xudong Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1513948

641 views

Correction

Published on 20 Mar 2025

Corrigendum: Astragalus–Scorpion drug pair inhibits the development of prostate cancer by regulating GDPD4-2/PI3K/AKT/mTOR pathway and autophagy

in Pharmacology of Anti-Cancer Drugs

Xujun You
Yongrong Wu
Qixin Li
Wen Sheng
Qing Zhou
Wei Fu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1417603

440 views

Original Research

Published on 19 Mar 2025

Cyperotundone promotes chemosensitivity of breast cancer via SRSF1

in Pharmacology of Anti-Cancer Drugs

Chao Li
Lin Wang
Zhaoyun Liu
Xinzhao Wang
Luhao Sun
Xiang Song
Zhiyong Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1510161

489 views

Systematic Review

Published on 19 Mar 2025

Immune checkpoint inhibitors-induced pancreatitis: a systematic review and real-world pharmacovigilance analysis

in Pharmacology of Anti-Cancer Drugs

Wei Fang
Huanping Wang
Xiaoran Zhang
Hongxia Zhu
Wei Yan
Yang Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1426847

855 views

Original Research

Published on 19 Mar 2025

The real-world analysis of adverse events with azacitidine: a pharmacovigilance study based on the FAERS and WHO-VigiAccess databases

in Pharmacology of Anti-Cancer Drugs

Zhaorui Wang
Linlin Guo
Youfu He
Baiquan Zhang
Yang Wang
Juan Ding

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1555838

987 views

Original Research

Published on 19 Mar 2025

Unravelling the antitumor mechanism of Ocoxin through cancer cell genomics

in Pharmacology of Anti-Cancer Drugs

Iera Hernandez-Unzueta
Uxue Telleria-Gonzalez
Ana María Aransay
José Ezequiel Martin Rodriguez
Eduardo Sanz
Joana Márquez

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1540217

497 views

Original Research

Published on 18 Mar 2025

Characteristic analysis of adverse reactions of histone deacetylase inhibitors based on WHO-VigiAccess

in Pharmacology of Anti-Cancer Drugs

Tongnan Yin
Yuyu Liu
Chenwen Li
Xinran Feng
Yumeng Lin
Zhongyu Qu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1563797

460 views